Search Results for "QVAR"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for QVAR. Results 1 to 10 of 11 total matches.

Comparison Chart: Correct Use of Inhalers for Asthma (online only)

   
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024  (Issue 1716)
open the cap when ready to take a dose ▶ QVAR Redihaler (beclomethasone) Hydrofluoroalkane Metered ...
View the Comparison Chart: Correct Use of Inhalers for Asthma
Med Lett Drugs Ther. 2024 Nov 25;66(1716):e196-8   doi:10.58347/tml.2024.1716c |  Show IntroductionHide Introduction

Table: Correct Use of Inhalers for COPD (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 07, 2020  (Issue 1606)
when ready to take a dose QVAR Redihaler (beclomethasone): www.accessdata.fda.gov/drugsatfda_docs ...
View the Table: Correct Use of Inhalers for COPD
Med Lett Drugs Ther. 2020 Sep 7;62(1606):e150-4 |  Show IntroductionHide Introduction

Nebulized Budesonide For Asthma in Children

   
The Medical Letter on Drugs and Therapeutics • Jan 22, 2001  (Issue 1096)
Double Strength 2 (Schering/Key) 84 µg/puff 168 µg bid 53.33 QVAR 3 (3M Pharm) 40 µg/puff 80 µg bid ...
The FDA has approved a nebulized suspension of the corticosteroid budesonide for maintenance treatment of persistent asthma in children one to eight years old.
Med Lett Drugs Ther. 2001 Jan 22;43(1096):6-7 |  Show IntroductionHide Introduction

Budesonide/Formoterol (Symbicort) for Asthma

   
The Medical Letter on Drugs and Therapeutics • Feb 11, 2008  (Issue 1279)
Beclomethasone dipropionate QVAR HFA (Teva) MDI (100 inh/unit) 40, 80 mcg/inhalation 40-320 mcg bid 5-11 yrs ...
A combination of the corticosteroid budesonide and the long-acting beta2-agonist formoterol (Symbicort - AstraZeneca) has become available in a metered dose inhaler for long-term maintenance treatment of asthma in patients ≥ 12 years old. A combination product that contains fluticasone propionate and salmeterol (Advair) is already available for this indication in the US. Neither one of these combinations is approved for acute treatment of asthma symptoms. A dry powder inhaler formulation of Symbicort has been available in Europe and Canada for several years.
Med Lett Drugs Ther. 2008 Feb 11;50(1279):9-11 |  Show IntroductionHide Introduction

A Combination of Fluticasone and Salmeterol For Asthma

   
The Medical Letter on Drugs and Therapeutics • Apr 16, 2001  (Issue 1102)
/puff) 2-4 puffs bid 1-2 puffs bid 53.33 QVAR 3 (3M) (40 µg/puff) 2-4 puffs bid 1-2 puffs bid 49.58 ...
Fluticasone propionate, an inhaled corticosteroid, and salmeterol xinafoate, a long-acting beta2-adrenergic agonist, are now available together in a dry-powder inhaler for maintenance treatment of patients with asthma. The new combination is not recommended for treatment of acute bronchospasm or for treatment of children less than 12 years old.
Med Lett Drugs Ther. 2001 Apr 16;43(1102):31-3 |  Show IntroductionHide Introduction

Mometasone (Asmanex Twisthaler) for Asthma

   
The Medical Letter on Drugs and Therapeutics • Dec 05, 2005  (Issue 1223)
1 Beclomethasone dipropionate QVAR HFA (IVAX) 2 40-80 mcg bid 5-11 yrs: metered-dose inhaler 100 ...
The FDA has approved marketing of the corticosteroid mometasone furoate in an orally inhaled dry powder formulation (Asmanex Twisthaler - Schering-Plough) for maintenance treatment of asthma in patients at least 12 years old. Mometasone is also available as a mid-potency topical corticosteroid cream (Elocon) and as an intranasal spray (Nasonex) for treatment of allergic rhinitis.
Med Lett Drugs Ther. 2005 Dec 5;47(1223):98-9 |  Show IntroductionHide Introduction

Ciclesonide (Alvesco) - A New Inhaled Corticosteroid for Asthma

   
The Medical Letter on Drugs and Therapeutics • Sep 22, 2008  (Issue 1295)
QVAR (IVAX) HFA MDI (100 inh/unit) 40-320 mcg bid 5-11 yrs: $70.88 40, 80 mcg/inhalation 40-80 mcg bid ...
The FDA has approved the marketing of the corticosteroid ciclesonide (Alvesco - Sepracor) in a hydrofluoroalkane (HFA) metered-dose inhaler formulation for maintenance treatment of asthma in patients >12 years old. Ciclesonide is also available in the US as a nasal spray for allergic rhinitis (Omnaris), and has been available for asthma in Europe since 2003.
Med Lett Drugs Ther. 2008 Sep 22;50(1295):75-6 |  Show IntroductionHide Introduction

Comparison Chart: Some Inhaled Drugs for Treatment of Asthma (online only)

   
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024  (Issue 1716)
Nebulizer 500 mcg qid PRN — 31.008 Inhaled Corticosteroids (ICSs) Beclomethasone dipropionate – QVAR ...
View the Comparison Chart: Some Inhaled Drugs for Treatment of Asthma
Med Lett Drugs Ther. 2024 Nov 25;66(1716):e192-5   doi:10.58347/tml.2024.1716b |  Show IntroductionHide Introduction

Fluticasone Furoate (Arnuity Ellipta) for Asthma

   
The Medical Letter on Drugs and Therapeutics • May 25, 2015  (Issue 1469)
/unit) 40-320 mcg bid 5-11 yrs: 40-80 mcg $139.503 dipropionate – QVAR (Teva) 40, 80 mcg/inh bid ...
The FDA has approved Arnuity Ellipta (GSK), a single-agent inhaler containing the corticosteroid fluticasone furoate, for once-daily maintenance treatment of asthma in patients ≥12 years old. Fluticasone furoate is also available in combination with the long-acting beta2-agonist vilanterol as Breo Ellipta for treatment of asthma and COPD.
Med Lett Drugs Ther. 2015 May 25;57(1469):76-9 |  Show IntroductionHide Introduction

Comparison Table: Inhaled Drugs for Treatment of COPD (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024  (Issue 1710)
– QVAR Redihaler (Teva) 40, 80 mcg/inh HFA MDI (120 inh/unit)11 40-320 mcg bid ▶ Should not be used ...
View the Comparison Table: Inhaled Drugs for Treatment of COPD
Med Lett Drugs Ther. 2024 Sep 2;66(1710):e143-7   doi:10.58347/tml.2024.1710b |  Show IntroductionHide Introduction